ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "COVID-19: Are markets mispricing the risk?"
Episode Synopsis
With recent highs on global equity indices, IGTV’s Jeremy Naylor asked Dr Navid Malik, Head of Life Sciences Research at The Life Sciences Division, whether investors and traders are getting ahead of themselves in pricing risk. Dr Malik, as well as being a medical doctor and an expert in COVID-19, is also an investor and runs the research desk at The Life Sciences Division.
In this episode, the discussion begins with the recent developments on how the virus seems to be mutating and then moves onto the ways in which pharma and biotech companies are rising to the challenge.
Any opinion, news, research, analysis, or other information does not constitute investment or trading advice.
Follow us on Twitter @IGcom
In this episode, the discussion begins with the recent developments on how the virus seems to be mutating and then moves onto the ways in which pharma and biotech companies are rising to the challenge.
Any opinion, news, research, analysis, or other information does not constitute investment or trading advice.
Follow us on Twitter @IGcom
More episodes of the podcast In the market for more
Buying the dip? | Talking Shop podcast
19/03/2025
Do you have trading biases?
06/02/2025
In God we trust